Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$510K Buy
1,210
+34
+3% +$13.6K 0.19% 56
2026
Q2
$426K Hold
1,176
– – 0.17% 59
2026
Q1
$414K Sell
1,176
-5
-0.4% -$1.78K 0.18% 59
2025
Q4
$387K Hold
1,181
– – 0.18% 57
2025
Q3
$333K Hold
1,181
– – 0.16% 51
2025
Q2
$330K Sell
1,181
-10
-0.8% -$2.83K 0.17% 51
2025
Q1
$371K Hold
1,191
– – 0.21% 47
2024
Q4
$311K Buy
+1,191
New +$353K 0.18% 54

Other funds holding AMGN

Causey Wealth's AMGN Position: Q3 2026 in Review

Causey Wealth increased its Amgen (AMGN) stake by 2.9% in Q3 2026, buying an estimated $13.6K and bringing the position to 1,210 shares worth $510K. The position accounts for 0.19% of the portfolio, ranked #56.

Causey Wealth first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Causey Wealth held 1,210 shares of Amgen worth $510K as of Q3 2026.
  • Causey Wealth bought 34 Amgen shares in Q3 2026, an estimated $13.6K.
  • Amgen made up 0.19% of Causey Wealth's portfolio in Q3 2026, its #56 holding.
  • Causey Wealth first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Causey Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.